Bioject Medical Technologies Inc.  

(Public, OTCMKTS:BJCT)   Watch this stock  
Find more results for bjct
Apr 4 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.00 - 0.12
Open     -
Vol / Avg. 0.00/2,423.00
Mkt cap 1,890.00
P/E     -
Div/yield     -
EPS -0.03
Shares 18.91M
Beta 0.04
Inst. own 97%

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -41.27% -65.95%
Operating margin -26.86% -63.33%
EBITD margin - -63.33%
Return on average assets -19.23% -49.30%
Return on average equity - -
Employees 33 -
CDP Score - -


7180 SW Sandburg St Ste 100
TIGARD, OR 97223-8163
United States - Map
+1-503-6928001 (Phone)
+1-503-6926698 (Fax)

Website links


Bioject Medical Technologies, Inc. is engaged in the development of needle-free injection therapies. The Company's products include Biojector 2000 Needle Free Injection System, which is an injection system designed for healthcare providers; Bioject ZetaJet, which consists of a portable injector and an auto-disabling disposable syringe; Bioject Drug Reconstitution System, which has a connector that allows the user to withdraw medication from a vial without using a needle, and Needle-Free Vial Adapter, which is a non-sharp plastic device that replaces a fill needle for accessing medication vials making syringe filling completely needle-free. Its technology platform delivers a range of medications and vaccines to the subcutaneous, intramuscular and intradermal depths. It has developed a portfolio of injection systems based on its technology that includes durable devices designed for heavy use in a healthcare environment, and small and lightweight injectors designed for home use.